vs
CorMedix Inc.（CRMD）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是CorMedix Inc.的1.3倍（$162.6M vs $128.6M）
CorMedix Inc.是一家处于商业阶段的生物制药企业，专注于开发及商业化用于预防和治疗感染性、炎症性及心肾疾病的创新治疗产品，核心管线针对导管相关血流感染，主要服务北美、欧洲的重症监护及长期透析患者群体。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
CRMD vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.3倍
$128.6M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $128.6M | $162.6M |
| 净利润 | — | $89.1M |
| 毛利率 | 83.4% | 42.9% |
| 营业利润率 | 46.0% | 37.6% |
| 净利率 | — | 54.8% |
| 营收同比 | — | -10.3% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.20 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRMDRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $128.6M | $227.3M | ||
| Q3 25 | $104.3M | $215.4M | ||
| Q2 25 | $39.7M | $220.6M | ||
| Q1 25 | $39.1M | $181.3M | ||
| Q4 24 | — | $251.4M | ||
| Q3 24 | — | $210.2M | ||
| Q2 24 | — | $192.6M |
净利润CRMDRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | — | — | ||
| Q3 25 | $108.6M | $-12.1M | ||
| Q2 25 | $19.8M | $-11.1M | ||
| Q1 25 | $20.6M | $-26.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-13.4M | ||
| Q2 24 | — | $-16.8M |
毛利率CRMDRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | 83.4% | 53.3% | ||
| Q3 25 | 89.3% | 50.1% | ||
| Q2 25 | 95.3% | 49.6% | ||
| Q1 25 | 95.9% | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
营业利润率CRMDRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 46.0% | 4.1% | ||
| Q3 25 | 49.2% | 1.3% | ||
| Q2 25 | 49.2% | 1.9% | ||
| Q1 25 | 51.5% | -10.8% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | -1.0% |
净利率CRMDRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | 104.1% | -5.6% | ||
| Q2 25 | 49.9% | -5.0% | ||
| Q1 25 | 52.8% | -14.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -6.4% | ||
| Q2 24 | — | -8.7% |
每股收益（稀释后）CRMDRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.20 | $0.50 | ||
| Q3 25 | $1.26 | $-0.07 | ||
| Q2 25 | $0.28 | $-0.06 | ||
| Q1 25 | $0.30 | $-0.15 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | — | $-0.08 | ||
| Q2 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.5M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $405.3M | $419.1M |
| 总资产 | $826.1M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRMDRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $148.5M | $96.4M | ||
| Q3 25 | $55.7M | $74.8M | ||
| Q2 25 | $190.7M | $60.5M | ||
| Q1 25 | $77.5M | $71.2M | ||
| Q4 24 | — | $87.8M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $64.6M |
总债务CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益CRMDRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $405.3M | $449.0M | ||
| Q3 25 | $374.1M | $360.1M | ||
| Q2 25 | $220.6M | $370.4M | ||
| Q1 25 | $114.9M | $381.8M | ||
| Q4 24 | — | $404.6M | ||
| Q3 24 | — | $395.5M | ||
| Q2 24 | — | $405.0M |
总资产CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | $826.1M | $1.2B | ||
| Q3 25 | $750.9M | $1.1B | ||
| Q2 25 | $252.6M | $1.1B | ||
| Q1 25 | $149.6M | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B |
负债/权益比CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.5M | — |
| 自由现金流经营现金流 - 资本支出 | $92.7M | — |
| 自由现金流率自由现金流/营收 | 72.1% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $172.8M | — |
8季度趋势，按日历期对齐
经营现金流CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | $94.5M | $29.2M | ||
| Q3 25 | $30.9M | $26.5M | ||
| Q2 25 | $30.0M | $-795.0K | ||
| Q1 25 | $19.7M | $-3.5M | ||
| Q4 24 | — | $61.8M | ||
| Q3 24 | — | $-14.8M | ||
| Q2 24 | — | $-9.8M |
自由现金流CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | $92.7M | $27.3M | ||
| Q3 25 | $30.4M | $21.0M | ||
| Q2 25 | $30.0M | $-6.5M | ||
| Q1 25 | $19.7M | $-15.7M | ||
| Q4 24 | — | $53.8M | ||
| Q3 24 | — | $-23.7M | ||
| Q2 24 | — | $-12.9M |
自由现金流率CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | 72.1% | 12.0% | ||
| Q3 25 | 29.1% | 9.7% | ||
| Q2 25 | 75.4% | -2.9% | ||
| Q1 25 | 50.5% | -8.7% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -6.7% |
资本支出强度CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 0.9% | ||
| Q3 25 | 0.5% | 2.6% | ||
| Q2 25 | 0.1% | 2.6% | ||
| Q1 25 | 0.0% | 6.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 1.6% |
现金转化率CRMDRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
